FIGURE 2.
Time from initiation of biologics to switching treatment in children with moderate–severe disease who were eligible vs ineligible for inclusion in the original randomised controlled trials.
Time from initiation of biologics to switching treatment in children with moderate–severe disease who were eligible vs ineligible for inclusion in the original randomised controlled trials.